Correlations of partial and extensive methylation at the p14(ARF) locus with reduced mRNA expression in colorectal cancer cell lines and clinicopathological features in primary tumors

Carcinogenesis

Volumn 21, Issue 11, 2000, Pages 2057-2064

  Zheng, S ^a   Chen, P ^a   McMillan, A ^a   Lafuente, A ^a   Lafuente, M J ^a   Ballesta, A ^a   Trias, M ^a   Wiencke, J K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; CHROMOSOME PROTEIN; MESSENGER RNA; PROTEIN P14; PROTEIN P16; PROTEIN P53; UNCLASSIFIED DRUG;

ADULT; AGE; AGED; ARTICLE; CANCER CELL CULTURE; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; DNA FLANKING REGION; EXON; FEMALE; GENE EXPRESSION REGULATION; GENE LOCUS; GENE TARGETING; HUMAN; HUMAN CELL; MALE; NUCLEOTIDE SEQUENCE; PATHOLOGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN METHYLATION; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEX DIFFERENCE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

ADULT; AGED; AGED, 80 AND OVER; BASE SEQUENCE; COLORECTAL NEOPLASMS; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EXONS; FEMALE; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEINS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SULFITES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P14ARF;

EID: 0033737604     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.11.2057     Document Type: Article

References (26)

1. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines
2. Microsatellite instability in colorectal cancer: Different mutator phenotypes and the principal involvement of hMLH1
3. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma
4. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia
5. 5' CpG island methylation is associated with transcriptional silencing of the tumour suppressor P16/CDKN2/MTS1 in human cancers
6. Inactivation of the CDKN2/P16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers
7. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
8. Aberrant methylation of p16(INK4a) in anatomic and gender specific subtypes of sporadic colorectal cancer
9. A novel p16(Ink4a) transcript
10. Two tracks but one race? Cancer genetics
11. Tumor suppression at the mouse INK4a locus mediated by the alternate reading frame product p19(ARF)
12. Tumor spectrum in ARF-deficient mice
13. The INK4a/ARF tumor suppressor: One gene, two products, two pathways
14. Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2
15. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
16. E1A signaling to p53 involves the p19(ARF) tumor suppressor
17. P19(ARF) links the tumour suppressor p53 to Ras
18. Interferon-γ independent effects of interleukin-12 administered during acute or established infection due to Leishmania major
19. Construction of polycompetitors for competitive PCR
20. The human ARF cell cycle regulatory gene promoter is a CpG island which can be silenced by DNA methylation and down-regulated by wild-type p53
21. The DNA methylation paradox
22. WiDr is a derivative of another colon adenocarcinoma cell line, HT-29
23. Low-level c-myc amplification in human colonic carcinoma cell lines and tumors: A frequent, p53-independent mutation associated with improved outcome in a randomized multiinstitutional trial
24. The oncogene and polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
25. The role of DNA methylation in expression of the p19/p16 locus in human bladder cancer cell lines
26. Inverse correlation between RER+ status and p53 mutation in colorectal cancer cell lines